K. M. Health Care
Sola, Ahmedabad, Gujarat
GST No.
24APDPK9037K1ZP
TrustSEAL
Verified
Call 08048262775
66% Response Rate
SEND EMAIL
Our Products
»
Anti Cancer Injection
Hepatitis Medicine
Anticancer Medicine
Pharmaceutical Tablet
Anti Cancer Medicines
Pharmaceutical Injection
Anticancer Injectable
Anticancer Capsule
Life Saving Drug
Anticancer Tablet
Anti Cancer Injections
Anticancer Medicines
Kidney Medicine
Antifungal Medicines
pharmaceutical injectables
Tablets
HIV Medicines
Antineoplastic Drug
Bevacizumab Injection
Injection
medicine
Pharmaceutical Tablet & Capsules
Cipcal D3 Cholecalciferol Granules
Desirox Tablet
Anti Cancer Tablet And Injection
Melphalan Tablets Ip
Inconel & Incoloy Pipe
Mycophenolate Mofetil
antivirus drug
Votrient Tablet
Letrozole Tablet
Dabigatran
Pharmaceutical Medicine And Injection
AntiCancer Injection
Anticancer Drugs
Sunitinibmalate Capsules
Lenalidomide
Heptatitis Medicines
New Items
Home
About Us
»
Testimonial
Why Us?
Distributor Enquiry Form
Download Brochure
Contact Us
Home
»
Our Products
»
Anti Cancer Tablet And Injection
Pioneers in the industry, we offer imfinzi durvalumab anti cancer injection and femara 2.5 mg tablets from India.
Imfinzi Durvalumab Anti Cancer Injection
Ask For Price
Product Price :
Get Latest Price
Product Details:
Manufacturer
Astra
Brand
Imfinzi
Prescription/Non prescription
Prescription
Imfinzi Contain : Durvalumab
Request
Callback
Yes! I am interested
Femara 2.5 Mg Tablets
Ask For Price
Product Price :
Get Latest Price
Product Details:
Dose/Strength
2.5 mg
Request
Callback
Yes! I am interested
X
Explore More Products
Paclitax Nab 100 Mg Injection
Get Best Quote
Hertraz Trastuzumab Injection
Get Best Quote
XGeva Denosumab 120mg Injection
Get Best Quote
Faslodex Fulvestrant 250mg
Get Best Quote
Lorbrena Lorlatinib
Get Best Quote
Eylea Aflibercept Injection
Get Best Quote
View All Products
Reach Us
Kalpesh Kosti (Proprietor)
K. M. Health Care
First, FF-12/a, I The Address, Nr Sola Overbridge
Ahmedabad - 380060, Gujarat, India
Get Directions
Call Us
Call Response Rate: 66%
Share Us
Facebook
Twitter
LinkedIn
Send E-mail